[{"id":"cadff643-56b0-4e97-baf3-eaa0cd1d40bf","acronym":"","url":"https://clinicaltrials.gov/study/NCT05693844","created_at":"2023-01-23T16:00:11.670Z","updated_at":"2024-07-02T16:35:04.514Z","phase":"Phase 1/2","brief_title":"Pan-T Booster Co-expressing MSLN CAR T Cell Therapy in Advanced/Metastatic Solid Tumors","source_id_and_acronym":"NCT05693844","lead_sponsor":"Chinese PLA General Hospital","biomarkers":" MSLN","pipe":" | ","alterations":" MSLN expression","tags":["MSLN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSLN expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e albumin-bound paclitaxel • cyclophosphamide • fludarabine IV • CD40 ligand expressing MSLN-CAR T"],"overall_status":"Recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 01/20/2023","start_date":" 01/20/2023","primary_txt":" Primary completion: 12/31/2025","primary_completion_date":" 12/31/2025","study_txt":" Completion: 12/31/2026","study_completion_date":" 12/31/2026","last_update_posted":"2024-05-10"}]